Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. (Q50940024)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2006

Language	Label	Description	Also known as
English	Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.	scientific article published in May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

multiple sclerosis

0 references

randomized controlled trial

1 reference

based on heuristic

inferred from title

pseudobulbar affect

1 reference

based on heuristic

inferred from title

6

object named as

Anat Achiron

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

author name string

Hillel S Panitch

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Ronald A Thisted

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Richard A Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Daniel R Wynn

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

James P Wymer

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Timothy L Vollmer

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Raul N Mandler

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Dennis W Dietrich

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Malcolm Fletcher

10

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Laura E Pope

11

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

James E Berg

12

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Ariel Miller

13

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Psuedobulbar Affect in Multiple Sclerosis Study Group

14

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

59

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

780-787

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FANA.20828

21 January 2018

Treatment of "emotional incontinence" with levodopa

1 reference

https://api.crossref.org/works/10.1002%2FANA.20828

21 January 2018

Pathologic laughing and crying treated with levodopa

1 reference

https://api.crossref.org/works/10.1002%2FANA.20828

21 January 2018

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FANA.20828

21 January 2018

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FANA.20828

21 January 2018

Identifiers

10.1002/ANA.20828

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/16634036

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50940024&oldid=1788076814"